| Dr Lexie Elizabeth Neubauer, MD | |
|
6379 Center Dr, Norfolk, VA 23502-4102 | |
| (757) 467-4200 | |
| Not Available |
| Full Name | Dr Lexie Elizabeth Neubauer |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 6379 Center Dr, Norfolk, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700415254 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 0101277956 (Virginia) | Primary |
| Entity Name | Emergency Physicians Of Tidewater |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033136841 PECOS PAC ID: 5092618462 Enrollment ID: O20040202000195 |
News Archive
Aphios® Corporation today announced that it was awarded United States Patent No. 7,744,935 B2 for "Compositions and Methods for Inhibiting 5-α Reductase," granted June 29, 2010. This invention is related to compositions and methods for treating diseases involving the 5-alpha (α) reductase enzyme.
Mesures magazine, a publication of Newsco Group, has announced the winners in ten measurement categories for its annual Technology Awards. METTLER TOLEDO is proud to have won the top spot among an esteemed field of lab equipment entries.
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for a crucial patent covering its leading tumor-targeted vaccine technology for cancer immunotherapy. The issuance of this valuable patent protection for tumor targeted immunotherapy follows on the heels of two international patents covering targeted gene medicine in the U.S. and Europe, respectively, and places Epeius Biotech at the forefront of these emerging fields of clinical medicine with best-of-breed solutions and incontrovertible proofs-of-principle in the clinic.
Chronic obstructive pulmonary disease (COPD) is one of most common causes of death in the world today - active smoking accounting for approx. 85% of all cases. Yet ground-breaking research from the University of Copenhagen indicates that accelerated decline of lung function is not a prerequisite for COPD.
Findings from three studies conducted by the U.S. Food and Drug Administration confirm that the way information is conveyed and displayed in printed drug advertising affects consumer understanding of prescription medications.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lexie Elizabeth Neubauer, MD 1001 Marble Walke Way, Virginia Beach, VA 23455-6774 Ph: (507) 461-1383 | Dr Lexie Elizabeth Neubauer, MD 6379 Center Dr, Norfolk, VA 23502-4102 Ph: (757) 467-4200 |
News Archive
Aphios® Corporation today announced that it was awarded United States Patent No. 7,744,935 B2 for "Compositions and Methods for Inhibiting 5-α Reductase," granted June 29, 2010. This invention is related to compositions and methods for treating diseases involving the 5-alpha (α) reductase enzyme.
Mesures magazine, a publication of Newsco Group, has announced the winners in ten measurement categories for its annual Technology Awards. METTLER TOLEDO is proud to have won the top spot among an esteemed field of lab equipment entries.
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for a crucial patent covering its leading tumor-targeted vaccine technology for cancer immunotherapy. The issuance of this valuable patent protection for tumor targeted immunotherapy follows on the heels of two international patents covering targeted gene medicine in the U.S. and Europe, respectively, and places Epeius Biotech at the forefront of these emerging fields of clinical medicine with best-of-breed solutions and incontrovertible proofs-of-principle in the clinic.
Chronic obstructive pulmonary disease (COPD) is one of most common causes of death in the world today - active smoking accounting for approx. 85% of all cases. Yet ground-breaking research from the University of Copenhagen indicates that accelerated decline of lung function is not a prerequisite for COPD.
Findings from three studies conducted by the U.S. Food and Drug Administration confirm that the way information is conveyed and displayed in printed drug advertising affects consumer understanding of prescription medications.
› Verified 1 days ago
Ruth Gordon, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6379 Center Dr, Norfolk, VA 23502 Phone: 757-467-4200 | |
Miss Kaci Elizabeth Gogel, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr Rm 304, Emergency Department, Norfolk, VA 23507 Phone: 757-388-3397 Fax: 757-388-2885 | |
Dr. Benjamin Lee Chidester, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Gresham Drive, Norfolk, VA 23507 Phone: 757-388-3000 | |
Dr. Moses Tucker Laffitte Iv, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Gresham Drive, Norfolk, VA 23507 Phone: 757-388-3000 | |
Theodore Tzavaras, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr, Suite 304, Norfolk, VA 23507 Phone: 757-388-3397 | |
Dr. Clay Kingsley Lifton, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr, Raleigh Building Room 304, Norfolk, VA 23507 Phone: 757-388-3397 | |
Rosemary Guerguerian, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7007 Fax: 757-668-8658 |